Novo Nordisk Expand Use of APAS Independence
Filed with ASX · · 2 pages · English
Summary by 6ix AI
Clever Culture Systems Limited has announced a purchase order from Novo Nordisk for two additional APAS® Independence instruments, increasing their total to three instruments at Novo Nordisk. This order includes the development of custom laboratory interface software to facilitate global deployment of the APAS® technology. The order is seen as an early indication of a positive sales outlook for the upcoming fiscal year, driven by the company's Land and Expand strategy targeting major pharmaceutical manufacturers. The instruments will be used for formal validation of the APAS® technology at a site in Denmark, supporting regulatory compliance for Good Manufacturing Practice.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Clever Culture Systems Limited on 6ix
Story so far
Earlier from Clever Culture Systems
- Appendix 4G
- Corporate Governance Statement
- Annual Report to shareholders
- Appendix 4E
- Application for quotation of securities - CC5
Later from Clever Culture Systems
- Notice of Annual General Meeting/Proxy Form
- Proposed issue of securities - CC5
- PSC Biotech Partnership Expands US Pharma Sales Reach
- Advancing Sales Pipeline Underpins Growth Momentum
- Change of Registry Address Notification
Follow Clever Culture Systems into a list and get an email when it puts out news.
Follow Clever Culture Systems